HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ann-Christin Buckendahl Selected Research

leptomycin B

7/2011An intracellular targeted antibody detects EGFR as an independent prognostic factor in ovarian carcinomas.
4/2008Expression of the nuclear export protein chromosomal region maintenance/exportin 1/Xpo1 is a prognostic factor in human ovarian cancer.
2/2008Expression of the ELAV-like protein HuR in human prostate carcinoma is an indicator of disease relapse and linked to COX-2 expression.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ann-Christin Buckendahl Research Topics

Disease

12Neoplasms (Cancer)
03/2012 - 11/2006
7Ovarian Neoplasms (Ovarian Cancer)
07/2011 - 04/2008
7Carcinoma (Carcinomatosis)
04/2011 - 02/2008
3Adenocarcinoma
07/2009 - 04/2006
3Carcinogenesis
05/2009 - 04/2006
2Colorectal Neoplasms (Colorectal Cancer)
12/2010 - 03/2008
2Residual Neoplasm
12/2009 - 06/2009
2Pancreatic Neoplasms (Pancreatic Cancer)
11/2009 - 11/2006
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
03/2012
1Diarrhea
03/2012
1Paronychia
03/2012
1Breast Neoplasms (Breast Cancer)
11/2010
1Neoplasm Metastasis (Metastasis)
12/2009
1Ovarian Epithelial Carcinoma
12/2009
1Endometrial Neoplasms (Endometrial Cancer)
07/2009
1Colonic Neoplasms (Colon Cancer)
03/2008
1Wounds and Injuries (Trauma)
03/2008
1Prostatic Neoplasms (Prostate Cancer)
02/2008
1Pancreatic Ductal Carcinoma
11/2006
1Lymphatic Metastasis
04/2006
1Stomach Neoplasms (Stomach Cancer)
04/2006

Drug/Important Bio-Agent (IBA)

8Proteins (Proteins, Gene)FDA Link
04/2011 - 04/2006
5Messenger RNA (mRNA)IBA
05/2010 - 02/2008
3leptomycin BIBA
07/2011 - 02/2008
2NF-kappa B (NF-kB)IBA
05/2010 - 11/2009
2Indicators and Reagents (Reagents)IBA
12/2009 - 02/2008
2ParaffinIBA
12/2009 - 04/2006
2Histone Deacetylase InhibitorsIBA
11/2009 - 03/2008
1Erlotinib Hydrochloride (CP 358,774)FDA Link
03/2012
1Biomarkers (Surrogate Marker)IBA
03/2012
1Glucose (Dextrose)FDA LinkGeneric
04/2011
1AMP-Activated Protein KinasesIBA
04/2011
1Histocompatibility Antigens Class IIBA
12/2010
1Progesterone Receptors (Progesterone Receptor)IBA
11/2010
1Estrogens (Estrogen)FDA Link
11/2010
1NF-KappaB Inhibitor alphaIBA
05/2010
1Formaldehyde (Formol)FDA Link
12/2009
1Vascular Endothelial Growth Factor CIBA
12/2009
1RNA (Ribonucleic Acid)IBA
12/2009
1DNA (Deoxyribonucleic Acid)IBA
11/2009
1MTOR InhibitorsIBA
07/2009
1Sirolimus (Rapamycin)FDA Link
07/2009
1PlatinumIBA
06/2009
1Paclitaxel (Taxol)FDA LinkGeneric
06/2009
1multidrug resistance-associated protein 1IBA
05/2009
1Carrier Proteins (Binding Protein)IBA
05/2009
1Insulin-Like Growth Factor II (Somatomedin A)IBA
05/2009
1Biological ProductsIBA
04/2008
1Exportin 1 ProteinIBA
04/2008
1Protein Isoforms (Isoforms)IBA
03/2008
1Histone Deacetylases (Histone Deacetylase)IBA
03/2008
1Small Interfering RNA (siRNA)IBA
03/2008
1ELAV-Like Protein 1IBA
02/2008
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
02/2008
1LigandsIBA
11/2006
1Transcription Factors (Transcription Factor)IBA
11/2006
1PPAR gammaIBA
11/2006
1Polo-Like Kinase 1IBA
04/2006

Therapy/Procedure

4Therapeutics
07/2011 - 02/2008
1Drug Tapering
03/2012
1Withholding Treatment
03/2012
1Cytoreduction Surgical Procedures
12/2009
1Protective Gloves
03/2008